Haemeto ist spezialisiert auf patentfreie und patentgeschützte Arzneimittel. Schwerpunkte bilden Therapien gegen Krebs, Autoimmunerkrankungen und anderen chronischen Krankheiten. Rund 70 % der Aktien hält die MPH Mittelständische Pharma Holding.

COMPANY

Haemato

INVESTOR TERMSHEET

#BGFL app

#BGFL Publisher

HAEK

Haemato

#BGFL Mood: - · #BGFL-Indicator: - · Review date: -

LEI: 529900Q3CGRYVCW7E340

SECTOR: Gesundheit SUB-SECTOR: Pharma

NAME

Haemato

WKN

A289VV

ISIN

DE000A289VV1

TICKER

HAEK

INDEX

EXCHANGE

Frankfurt

BUY SELL

Made with ❤ von BGFL

#BGFL

Newswire

Ratings

#BGFL-nes Haemato: boersengefluester.de (BGFL) regularly writes extensive editorial articles for most of the companies in our database - especially those in the special stocks sector. Here we show you a list of the most recent articles by BGFL on the selected share.

No data

Newswire Haemato: Official company news is an enormously important source of information for investors - especially if it is particularly price-sensitive and therefore subject to ad hoc disclosure. Here we show the reports provided by the IR portal EQS News on companies from the BGFL coverage universe.

30.11.2023	EQS-Adhoc: HAEMATO AG: Termination of listing in the Open Market
16.11.2023	EQS-News: HAEMATO AG publishes figures for the third quarter of 2023: Sales increase of around 13% compared to the same period of the previous year, strong increase in EBIT margin and significant increase in
15.11.2023	EQS-Adhoc: Termination of the botulinum toxin project
15.02.2022	HAEMATO adds a new generation test device to its portfolio

Resaerch for Haemato: Independent research is hard to find, especially in the speciality stocks sector. However, there are a number of firms that regularly produce meaningful analyses of the companies they cover. As a rule, this is paid research - but the analyses are definitely worth reading.

15.12.2023	Original-Research: HAEMATO AG (von GBC AG): suspended
13.12.2023	Original-Research: Haemato AG (von First Berlin Equity Research GmbH): Not Rated
10.12.2021	Original-Research: HAEMATO AG (von GBC AG): Management Interview

The #BGFL Coverage App Gallery

Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.

Corporate Name Change

Financial Calendar

Interviews, Quotes, Analyses

IR-Quick Check

Annual Reports

Does news drive share prices or does the chain of effects run the other way round - as is often assumed? Well, at boersengefluester.de we offer you all kinds of ways to follow daily stock market events. Take a look at our apps on the subject of news.

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.

Haemato

Quick Links

Network

Partner

Contact

Haemato

Would you like to see fewer adverts? Simply register for a user account. Registration is free and significantly reduces the number of adverts.

Quick Links

Network

Partner

Contact